Articles tagged with Activity Assays
Researchers developed a new way to uncover differences in how viruses infect and destroy individual microbial cells. The study used a mathematical modeling framework to analyze infection outcomes in individual cells, revealing striking accuracy and new insights into viral behavior.
Researchers from the University of California, Davis, present a comprehensive framework for analyzing longitudinal activity and behavior. By employing advanced statistical techniques, they explore the relationship between activity and age-at-death in Mediterranean fruit flies, shedding light on potential links to human lifespan.
Researchers identify the minimum contribution of TACC3 for FGFR3-TACC3 fusion protein activation, revealing a novel target for treating FGFR translocation-driven cancers. The study shows that clinically identified FGFR3-TACC3 fusion proteins differ in biological activity depending on specific breakpoints.
Scientists have devised a method to pinpoint active ingredients from traditional Chinese medicine formulations, revealing 4 analytes with significant anti-inflammatory activity. This breakthrough could improve quality control standards and lead to better herbal remedies.
A team of researchers developed a high-throughput biochemical assay to assess small molecule impact on SARS-CoV-2 nonstructural protein 14, identifying potential inhibitors from FDA-approved drugs. The study aims to deliver therapeutics for the SARS-CoV-2 virus, targeting its critical methyltransferase activity.
Researchers created a novel Drosophila-based disease model for Pitt-Hopkins syndrome (PTHS), which is caused by mutations in the TCF4 gene. The model reveals that certain substances can enhance learning and locomotor abilities in PTHS patients, suggesting potential therapeutic options.
The October edition of SLAS Discovery features a critical review of mass spectrometry applied to imaging in drug discovery, highlighting its potential for pharmacokinetic and pharmacodynamic measurements. The issue also includes original research articles on various topics in life sciences discovery and technology.
A study by Professor Johannes Knobloch found that European coins made from antimicrobial metals like copper display detectable antimicrobial activity against bacteria, reducing bacterial cell counts by up to 99.5% after 24 hours. However, coins may still act as vectors for the transmission of microbes.
InDevR's new VaxArray kit offers a standardized method to measure neuraminidase in influenza vaccines, improving accuracy and precision. This assay is expected to aid in the development of more broadly protective flu vaccines by enabling manufacturers to meet current regulatory requirements.
Researchers have identified plant-derived volatiles with potent vapour-phase-mediated anti-Candida activity, offering a potential solution to the growing problem of drug resistance. Approximately half of the tested essential oils and their components showed activity against the most drug-resistant type of Candida.
A new homogeneous assay detects succinate using luminescence, enabling the investigation of a large number of structurally conserved enzymes belonging to the Fe(II)/2-oxoglutarate-dependent dioxygenase superfamily. This method has significant applications in dioxygenase research and has the potential to impact human diseases.
Researchers developed a high-throughput screening strategy that identified multiple compounds with potent antimicrobial activity against an antibiotic-resistant strain of Klebsiella pneumoniae. The study also showed the potential of these compounds as adjunctive treatments to restore the effectiveness of antibiotics.
Scientists at Scripps Research Institute have developed a device called LIGHTSABR that can screen millions of compounds in a week for about $500. The device overcomes technical challenges in miniaturized screening and allows users to adjust the dose of the compound being tested.
Researchers are developing novel hit-to-lead drug discovery strategies utilizing a combination of high-throughput screening, miniaturization, and advanced data analysis. This approach enables the identification of promising compounds with increased efficiency, leading to faster and more effective disease treatments.
Researchers used bioassay-guided evolution to identify more efficient antibiotic-producing mutants in Escherichia coli, reconstituting the biosynthetic pathways of sugars to yield a new antibiotic. This approach opens doors for harnessing genetics to investigate polyketide synthases and biosynthetic engineering.
Researchers identified two small molecules with remarkable efficacy against botulinum neurotoxin A in animal models. The compounds showed surprisingly little activity in cell-based assays, highlighting the importance of animal-based studies. No significant side effects were observed with either molecule.
Mushrooms contain high levels of polyphenols and ergothioneine, which contribute to their antioxidant properties. The study found portabella and crimini mushrooms have the highest ORAC values, indicating they are a valuable addition to a varied diet.
A study found that telomerase activity in urine has high sensitivity and specificity for detecting bladder cancer, particularly in high-risk subgroups. The test is noninvasive, inexpensive, and easy to perform, making it a promising diagnostic tool for early cancer detection.
Researchers designed a new cyclen-based receptor that strongly binds the fluorescent dye pyranine under near-physiological conditions. The assay enhances the evaluation of developmental drug compounds' properties, improving the development of safer drugs.